Emergency gynaecology

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 20, Issue 5, 2006, Pages 729-750

  Ramphal, S R ^a   Moodley, J ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

ectopic pregnancies; miscarriages; pelvic inflammatory disease; randomised controlled trial

Indexed keywords

ANTIBIOTIC AGENT; ANTIGESTAGEN; CEFOTETAN; CEFOXITIN; CEFTRIAXONE; CEPHALOSPORIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CLINDAMYCIN; CYTOTOXIC AGENT; DOXYCYCLINE; FOLINIC ACID; GENTAMICIN; GLUCOSE; LEVOFLOXACIN; METHOTREXATE; METRONIDAZOLE; MIFEPRISTONE; MISOPROSTOL; OFLOXACIN; PLACEBO; PROBENECID; PROGESTERONE; PROSTAGLANDIN; SULPROSTONE; SULTAMICILLIN; UREA;

ADNEXA DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; DRUG DOSE REGIMEN; ECTOPIC PREGNANCY; EMERGENCY HEALTH SERVICE; ENDOMETRIUM BIOPSY; FERTILITY; HUMAN; LAPAROSCOPY; LAPAROTOMY; MAINTENANCE DRUG DOSE; META ANALYSIS; MICROBIOLOGICAL EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT; OVARY CYST; PELVIC INFLAMMATORY DISEASE; PREGNANCY RATE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; REPRODUCTIVE HEALTH; REVIEW; SALPINGECTOMY; SALPINGOSTOMY; SEROLOGY; SEXUAL FUNCTION; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; TUBOOVARIAN ABSCESS; UNSPECIFIED SIDE EFFECT;

ABORTION, SPONTANEOUS; EMERGENCY MEDICAL SERVICES; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; LAPAROSCOPY; LAPAROTOMY; MAGNETIC RESONANCE IMAGING; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PREGNANCY, ECTOPIC; SALPINGOSTOMY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33749257520     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2006.04.001     Document Type: Review

References (117)

1. Sackett D.L., Rosenberg W.M.C., Gray J.A.M., et al. Evidence based medicine: what it is and what it isn't. British Medical Journal 312 (1996) 71-72
2. Field M.J., and Lohr K.N. Guidelines for Clinical Practice. Institute of Medicine (1992), National Academy Press, Washington DC p. 34
3. Goldner T.E., Lawson H.W., Xia Z., and Atrash H.L.K. Surveillance of ectopic pregnancy: United States 1970-89. MMWR, CDC Surveillance Summaries 42 (1993) 73-85
4. Sperling R.S., Friedman Jr. F., Joyner M., et al. Seroprevalence of human immunodeficiency virus in women admitted to the hospital with pelvic inflammatory disease. Journal of Reproductive Medicine 36 (1991) 122-124
5. Goldstein S.R., Snyder G.R., Watson C., and Danon M. Very early pregnancy detection with endovaginal ultrasound. Obstetrics and Gynecology 72 (1988) 200-204
6. Cartwright P.S. Diagnosis of ectopic pregnancy. Obstetrics and Gynecology Clinics of North America 18 (1991) 19-37
7. Read M.D., and Bigrigg M.A. The management of gynaecological emergencies. Current Obstetrics and Gynaecology 4 (1994) 98-103
8. Lindblom B., Hahlin M., and Sjoblom P. Serial human chorionic gonadotrophin determinations by fluoroimmuno-assay for differentiation between intrauterine and ectopic gestation. American Journal of Obstetrics and Gynecology 161 (1989) 397-400
9. Cacciatore B., Stenman U.H., and Ylostalo P. Diagnosis of ectopic pregnancy by vaginal ultrasonography in combination discriminatory serum HCG level of 1000IU/L(IRP). British Journal of Obstetrics and Gynaecology 97 (1990) 904-908
10. Mol B., Lijmer T., Ankum W., et al. The accuracy of single serum progesterone measurement in the diagnosis of ectopic pregnancy: a meta-analysis. Human Reproduction 13 (1998) 3220-3227
11. Garry R. Towards evidence-based management of tubal ectopic pregnancies. Gynaecological Endoscopy 8 (1999) 65-70
12. Murphy A.A., Nager C.W., Wujek J.J., et al. Operative laparoscopy vs laparotomy for the management of ectopic pregnancy: a prospective trial. Fertility and Sterility 57 (1992) 1180-1185
13. Vermesh M., Silva P.D., Rosen G.F., et al. Management of ruptured ectopic gestation by linear salpingostomy: a prospective randomized clinical trial of laparoscopy vs laparotomy. Obstetrics and Gynecology 73 (1989) 400-404
14. Lundorff P., Thorburn J., Hahlin M., et al. Laparoscopic surgery in ectopic pregnancy; a randomized trial vs laparotomy. Acta Obstetricia et Gynecologica Scandinavica 70 (1991) 343-348
15. Lundorff P., Hahlin M., Kallfelt B., et al. Adhesion formation after laparoscopic surgery in tubal pregnancy: a randomized trial versus laparotomy. Fertility and Sterility 55 (1991) 911-915
16. Yao M., and Tulandi T. Current status of surgical and nonsurgical management of ectopic pregnancy. Fertility and Sterility 67 (1997) 421-433
17. Bangsgaard N., Lund C., Ottesen B., and Nilas L. Improved fertility following conservative surgical treatment of ectopic pregnancy. British Journal of Obstetrics and Gynaecology 110 (2003) 765-770
18. Pouly J.L., Mahnes H., Mage G., et al. Conservative laparoscopic treatment of 321 ectopic pregnancies. Fertility and Sterility 46 (1986) 1093-1097
19. Maymon R., Shulman A., Halperin R., et al. Ectopic pregnancy and laparoscopy - Review of of 1197 patients treated by salpingectomy or salpingostomy. European Journal of Obstetrics, Gynecology, and Reproductive Biology 62 (1995) 61-67
20. Dubuisson J.B., Morice B., Chapron C., et al. Salpngectomy - the laparoscopic surgical choice for ectopic pregnancy. Human Reproduction 11 (1996) 1199-1203
21. Seifer D.B. Persistent ectopic pregnancy: an argument for heightened vigilance and patient compliance. Fertility and Sterility 68 (1997) 402-404
22. Saraj A., Wilcox J., Najmabadi S., et al. Resolution of hormonal markers of ectopic gestation: a randomized trial comparing single dose intramuscular MTX with salpingostomy. Obstetrics and Gynecology 92 (1998) 989-994
23. Sowter M., Farquhar C., Petrie K., and Gudex G. A randomized trial comparing single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured tubal pregnancy. British Journal of Obstetrics and Gynaecology 108 (2001) 192-203
24. Sowter M., Farquhar C., and Gudex G. An economic evaluation of single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured ectopic pregnancy. British Journal of Obstetrics and Gynaecology 108 (2001) 204-212
25. Kooi S., and Kock H.C.L.V. A review of literature on nonsurgical treatment in tubal pregnancies. Obstetrical and Gynecological Survey 47 (1992) 739-749
26. Nazac A., Gervaise A., Bouyer J., et al. Predictors of success in methotrexate treatment of women with unruptured tubal pregnancies. Ultrasound in Obstetrics and Gynecology 21 (2003) 181-185
27. Fernandez H., Bourger P., Ville Y., et al. Treatment of unruptured tubal pregnancy with methotrexate: pharmacokinetic analyses of local vs intramuscular administration. Fertility and Sterility 62 (1994) 943-947
28. Hajenius P.J., Engelsbel S., Mol B.W., et al. Randomised trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancy. Lancet 350 (1997) 774-779
29. Henry M.A., and Gentry W.L. Single injection of methotrexate for treatment of ectopic pregnancies. American Journal of Obstetrics and Gynecology 171 (1994) 1584-1587
30. Stovall T.G., and Ling F.W. Single dose methotrexate: an expanded clinical trial. American Journal of Obstetrics and Gynecology 168 (1993) 1759-1765
31. Sowter M., and Frappell J. The role of laparoscopy in the management of ectopic pregnancy. Reviews in Gynaecological Practice 2 (2002) 273-282
32. Lipscomb G., McCord M., Stovall T., et al. Predictors of success of methotrexate treatment in women with ectopic pregnancies. The New England Journal of Medicine 341 (1999) 1974-1978
33. Lipscomb C., Bran D., McCord M., and Portera J. Analyses of three hundred and fifteen ectopic pregnancies treated with single dose methotrexate. American Journal of Obstetrics and Gynecology 178 (1998) 1354-1358
34. Parker J., Bisits A., and Proietto A.M. A systematic review of single-dose intramuscular methotrexate for the treatment of ectopic pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology 88 (1996) 775-778
35. Barnhart K., Gosman G., Ashby R., and Sammel M. The medical management of ectopic pregnancy: a meta-analysis comparing single dose and multidose regimens. Obstetrics and Gynecology 101 (2003) 778-784
36. Gamzu R., Almog B., Levin Y., et al. Efficacy of methotrexate treatment in extrauterine pregnancies defined by stable or increasing human chorionic gonadotrophin concentrations. Fertility and Sterility 77 (2002) 761-765
37. Potter M., lopine L., and Jamieson D. Predictors of success with methotrexate treatment of tubal ectopic pregnancy at Grady Memorial hospital. American Journal of Obstetrics and Gynecology 188 (2003) 1192-1194
38. Jacobson L., and Westrom L. Objectivized diagnosis of acute pelvic inflammatory disease. American Journal of Obstetrics and Gynecology 105 (1969) 1088-1098
39. Munday P.E. Pelvic inflammatory disease - an evidence-based approach to diagnosis. The Journal of Infection 40 (2000) 31-41
40. Simms I., Warburton F., and Westrom L. Diagnosis of pelvic inflammatory disease: time for a rethink. Sexually Transmitted Infections 79 (2003) 491-494
41. Meller B.R., Freundt E.A., and Mardh P.A. Experimental pelvic infection provoked by Chlamydia trachomatis and Mycoplasma hominis in grivet monkeys. American Journal of Obstetrics and Gynecology 138 (1980) 990-995
42. Sweet R.L., Draper D.L., Schachter J., and James J. Microbiology and pathogenesis of acute salpingitis as determined by laparoscopy: what is the appropriate site to sample?. American Journal of Obstetrics and Gynecology 138 (1980) 985-989
43. Spirtos N.J., Bernstine R.L., Crawford W.L., and Fayle J. Sonography in acute pelvic inflammatory disease. Journal of Reproductive Medicine 27 (1982) 312-320
44. Rowling S.E., and Ramchandani P. Imaging of the fallopian tubes. Seminars in Roentgenology 31 (1996) 299-311
45. Ignacio E.A., and Hill M.C. Ultrasound of the acute female pelvis. Ultrasound Quarterly 19 (2003) 86-98
46. Tukeva T.A., Aronen H.J., Karjalainen P.T., et al. MR imaging in pelvic inflammatory disease: comparison with laparoscopy and ultrasound. Radiology 210 (1999) 209-216
47. Timor-Tritsch I.E., Lerner J.P., Monteagudo A., et al. Transvaginal sonographic markers of tubal inflammatory disease. Ultrasound in Obstetrics and Gynecology 12 (1998) 56-66
48. Lehtinen M., Laine S., Heinonen P.K., et al. Serum C-reactive protein determination in acute pelvic inflammatory disease. American Journal of Obstetrics and Gynecology 154 (1986) 158-159
49. Bevan C.D., Johal B.J., Mumtaz G., et al. Clinical, laparoscopic and microbiological findings in acute salpingitis: report on a UK cohort. British Journal of Obstetrics and Gynaecology 102 (1995) 407-414
50. PeIpert J.F., Boardman L., Hogan J.W., et al. Laboratory evaluation of acute upper genital tract infection. Obstetrics and Gynecology 87 (1996) 730-736
51. Centers for Disease Control and Prevention. Sexually transmitted disease treatment guidelines. Recommendation and reports. MMWR 51 RR-6 (2002)
52. Peipert J.F., Ness R.B., Soper D.E., et al. Association of lower genital tract inflammation with objective evidence of endometritis. Infectious Diseases in Obstetrics and Gynecology 8 (2000) 83-87
53. Alexis T., Epperly A., and Viera A.J. Pelvic inflammatory disease. Clinics in Family Practice 7 (2005) 67-78
54. Walker C.K., Kahn J.G., Washington A.F., et al. Pelvic inflammatory disease: meta-analysis of antimicrobial regimen efficacy. Journal of Infectious Diseases 168 (1993) 969-978
55. Walker C.K., Workowski K.A., Washington A.F., et al. Anaerobes in pelvic inflammatory disease: implications for the centers for disease control and preventions guidelines for treatment of sexually transmitted disease. Clinical Infectious Diseases 28 (1999) S29-S36
56. Grimes D.A. Intrauterine device and upper genital tract infection. Lancet 356 (2000) 1013-1019
57. Soderberg G., and Lindgren S. Influence of an intrauterine device on the course of an acute salpingitis. Contraception 24 (1981) 127-143
58. Teisala K. Removal of an intrauterine device and the treatment of acute pelvic inflammatory disease. Annals of Medicine 21 (1989) 63-65
59. Hadgu A.H., Westrom L., Brooks C.A., et al. Predicting acute pelvic inflammatory disease: a multivariate analyses. American Journal of Obstetrics and Gynecology 155 (1986) 954-960 [Erratum: American Journal of Obstetrics and Gynecology 1987; 156: 264]
60. Zeger W., and Holt K. Gynaecologic infections. Emergency Medicine Clinics of North America 21 (2003) 631-648
61. Landers D.V. Tubo-ovarian abscess complicating PID. In: Landers D.V., and Sweet R.L. (Eds). Pelvic Inflammatory Disease (1997), Springer-Verlag, New York 94-106
62. Rubeinstein P.R., Mishell Jr. D.R., and Ledger W.J. Colpotomy drainage of pelvic abscess. Obstetrics and Gynecology 48 (1976) 142-145
63. Worthen N.J., and Gunning J.E. Percutaneous drainage of pelvic abscess: management of the tubo-ovarian abscess. Journal of Ultrasound in Medicine 5 (1986) 551-556
64. Corsi P.J., Johnson S.C., Gonik B., et al. Transvaginal ultrasound-guided aspiration of pelvic abscesses. Obstetrics and Gynecology 80 (1992) 555-557
65. Aboulghar M.A., Mansour R.T., and Serous G.I. Ultrasonographically guided transvaginal aspiration of tubo-ovarian abscesses and pyosalpinges: an optional treatment for acute pelvic inflammatory disease. American Journal of Obstetrics and Gynecology 172 (1995) 1501-1503
66. Caspi B., Salel Y., Or Y., et al. Sonographically guided aspiration: an alternative for tubo-ovarian abscess. Ultrasound in Obstetrics and Gynecology 7 (1996) 439-442
67. Kline J., Stein Z., and Susser M. Conception to birth. Epidemiology of prenatal development. Monographs in Epidemiology and Biostatistics vol. 14 (1989), Oxford University Press, Oxford
68. Scott J.R. Early pregnancy loss. In: Scott J.R., Di Sai P.J., Hammond C.B., et al. (Eds). Danforths Obstetrics and Gynaecology. 8th edn. (1999) 143-153
69. Pandya P.P., Snijders R.J., Psara N., et al. The prevalence of non-viable pregnancy at 10-13 weeks of gestation. Ultrasound in Obstetrics and Gynecology 7 (1996) 170-173
70. Falco P., Milano V., Pilu G., et al. Sonography of pregnancies with first trimester bleeding and a viable embryo: a study of prognostic indicators by logistic regression analysis. Ultrasound in Obstetrics and Gynecology 7 (1996) 165-169
71. Tongsong T., Wanapirak C., Srisomboon J., et al. Transvaginal ultrasound in threatened abortion with empty gestational sacs. International Journal of Gynaecology and Obstetrics 46 (1994) 297-301
72. Brown D.L., Emerson D.S., Felker R.E., et al. Diagnosis of early embryonic demise by endovaginal sonography. Journal of Ultrasound in Medicine 9 (1990) 631-636
73. Tongsong T., Srisomboon J., Wanapirak C., et al. Pregnancy outcome of threatened abortion with demonstrable fetal cardiac activity: a cohort study. Journal of Obstetrics and Gynaecology 21 (1995) 331-335
74. Tannirandorn Y., Sangswang S., Manotaya S., et al. Fetal loss in threatened abortion after embryonic/fetal heart activity: a cohort study. International Journal of Gynaecology and Obstetrics 81 (2003) 262-266
75. Everett C.B., and Preece F. Women with bleeding in the first 20 weeks of pregnancy: value of general practice ultrasound in detecting fetal heart movement. The British Journal of General Practice 46 (1996) 7-9
76. La Marca A., Morgante O., and De Leo V. Human chorionic gonadotrophin and immunological indices in threatened abortion. Obstetrics and Gynecology 92 (1998) 206-211
77. al-Sebai M.A., Diver M., and Hipkin I.J. The role of a single free beta-human chorionic gonadotrophin measurement in the diagnosis of early pregnancy failure and the prognosis of fetal viability. Human Reproduction 11 (1996) 881-888
78. Makrydimas G., Sebire N.J., Lolis D., and Vlassis N. Fetal loss following ultrasound diagnosis of a live fetus at 6-10 weeks of gestation. Ultrasound in Obstetrics and Gynecology 22 (2003) 368-372
79. Reljie M. The significance of crown-rump length measurement for predicting adverse pregnancy outcome of threatened abortion. Ultrasound in Obstetrics and Gynecology 17 (2001) 510-512
80. Bennet G.L., Bromley B., Lieberman E., and Benacerrat B.R. Sub-chorionic hemorrhage in first-trimester pregnancies: prediction of pregnancy outcome with sonography. Radiology 200 (1996) 803-806
81. Pederson J.F., and Mantoni M. Prevalence and significance of subchorionic haemorrhage in threatened abortion: a sonographic study. American Journal of Roentgenology 154 (1990) 535-537
82. Al-Sebai M.A., Diver M., and Hipkin I.J. The role of a single free beta-human chorionic gonadotrophin measurement in the diagnosis of early pregnancy failure and the prognosis of fetal viability. Human Reproduction 11 (1996) 881-888
83. Al-Sebai M.A., Kingsland C.R., Diver M., and Hipkin L. The role of a single progesterone measurement in the diagnosis of early pregnancy failure and the prognosis of fetal viability. British Journal of Obstetrics and Gynecology 102 (1995) 364-369
84. Ruge S., Pederson J.F., Sorensen S., and Lange A.P. Can pregnancy associated plasma protein A (PAPPA-A) predict the outcome in women with threatened abortion and fetal viability?. Acta Obstericia et Gynecologica Scandinavica 69 (1990) 580-595
85. Walraven J.W., Smith D.L., Applewhite M.P., et al. An evaluation of bed rest in threatened miscarriage. Academic Emergency Medicine 4 (1997) 492
86. Chamberlain G. Vaginal bleeding in early pregnancy. British Medical Journal 302 (1991) 1141-1143
87. Harrison R.F. A comparative study of human chorionic gonadotrophin, placebo, and bed rest for women with early threatened abortion. International Journal of Fertility and Menopausal Studies 38 (1993) 160-165
88. Ben Haroush A., Yogev Y., Mashiach R., and Meizner I. Pregnancy outcome of threatened abortion with subchorionic haematoma: possible benefit of bed rest?. The Israel Medical Association Journal 5 (2003) 422-424
89. Everett C., Ashurst H., and Chalmers I. Reported management of threatened miscarriage by general practioners in Wessex. British Medical Journal 295 (1987) 583-586
90. Donati S., Baglio G., Spinelli A., and Grandolfo M.E. Drug use in pregnancy among Italian Women. European Journal of Clinical Pharmacology 56 (2000) 323-328
91. Oates-Whitehead R.M., Haas D.M., and Carrier J.A.K. Progestogen for preventing miscarriage. Cochrane Library: Issue 4 (2005), Wiley, Chichester
92. Moller K., and Fuchs F. Double blind controlled trial of 6-methyl 17-acetoxyprogesterone in threatened abortion. Journal of Obstetrics and Gynaecology of the British Commonwealth 72 (1965) 1042-1044
93. Gerhard I., Gwinner B., Eggert-Kruse W., and Runnebaum B. Double-blind controlled trial of progesterone substitution in threatened abortion. Biological Research in Pregnancy and Perinatology 8 (1987) 26-34
94. Biggrigg M.A., and Read M.D. Management of women referred to early pregnancy assessment unit: care and cost effectiveness. British Medical Journal 302 (1991) 577-579
95. Wren J., and Craven B. A cost effectiveness study of changing medical practice in early pregnancy. Clinical Performance and Quality Health Care 7 (1999) 172-177
96. Neugebauer R., Kline J., O'conner P., and Shrout P. Depressive Symptoms in women in the 6 months after miscarriage. American Journal of Obstetrics and Gynecology 166 (1992) 104-109
97. Farrel R.G., Stonington D.T., and Ridgeway R.A. Incomplete and inevitable abortion: treatment by suction curettage in the emergency department. Annals of Emergency Medicine 11 (1982) 652-658
98. Greenslade FC, Leonard AL & Benson J. Manual Vacuum Aspiration. A Summary of Clinical and Programmatic Experience Worldwide. IPAS, 1993.
99. Klein S.M., and Garcia C.R. Asherman's syndrome: a critique and current review. Fertility and Sterility 24 (1973) 722-735
100. Verkuyl D.A., and Crowther C.A. Suction conventional curettage in incomplete abortions: a randomized controlled trial. South African Medical Journal 83 (1993) 13-15
101. Forna F., and Gulmezoglu A.M. Surgical procedures to evacuate incomplete abortions. Cochrane Library: Issue 4 (2005), Wiley, Chichester
102. May W., Gulmezoglu A.M., and Ba-Thike K. Antibiotics for incomplete abortion. Cochrane Library: Issue 4 (2005), Wiley, Chichester
103. Hinshaw H.K.S. Medical management of miscarriage. In: Grudzinskas J.G., and O'Brien P.M.S. (Eds). Problems in Early Pregnancy: Advances in Diagnosis and Management (1997), RCOG Press, London 284-295
104. Henshaw R.C., Cooper K., el-Refaey H., et al. Medical management of miscarriage: non-surgical uterine evacuation of incomplete and inevitable spontaneous abortion. British Medical Journal 306 (1993) 894-895
105. Moodliar S., Bagratee J.S., and Moodley J. Medical vs surgical evacuation of first- trimester spontaneous abortion. International Journal of Gynaecology and Obstetrics 91 (2005) 21-26
106. de Jonge E.T.M., Makin J.D., Manefeldt E., et al. Randomised clinical trial of medical evacuation and surgical curettage for incomplete miscarriage. British Medical Journal 311 (1995) 662-667
107. Nielsen S., and Hahlin M. Expectant management of first trimester spontaneous abortion. Lancet 345 (1995) 84-86
108. Chipchase J., and James D. Randomised trial of expectant versus surgical management of spontaneous miscarriage. British Journal of Obstetrics and Gynaecology 104 (1997) 840-841
109. Jurkovic D., Ross J.A., and Nicolaides K.H. Expectant management of missed miscarriage. British Journal of Obstetrics and Gynaecology 105 (1998) 670-671
110. Geyman J.P., Oliver L.M., and Sullivan S.D. Expectant, medical, or surgical treatment of spontaneous abortion in first trimester of pregnancy? A pooled quantitative literature evaluation. Journal of the American Board of Family Practice 12 (1999) 55-64
111. Rulin M.C., Bornstein S.G., and Campbell J.D. The reliability of ultrasonography in the management of spontaneous abortion, clinically thought to be complete: a prospective study. American Journal of Obstetrics and Gynecology 168 (1993) 12-15
112. Chung T.K., Cheung L.P., and Sahota D.S. Spontaneous abortion: short term complications following either conservative or surgical management. Australian and New Zealand Journal of Obstetrics and Gynaecology 38 (1998) 61-64
113. Bagratee J.S., Khullar V., Regan L., et al. A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Human Reproduction 19 (2004) 266-271
114. Spitz I.M., Bardin C.W., Benton L., and Robbins A. Early pregnancy termination with mifepristone and misoprostol in the united states. The New England Journal of Medicine 338 (1998) 1241-1247
115. Kulier R., Gulmezoglu, Hofmeyer G., et al. Medical methods for first trimester abortion. Cochrane Library: Issue 4 (2005), Wiley, Chichester
116. Baulieu E.E. RU 486 (mifepristone) - a short overview of its mechanisms of action and clinical uses at the end of 1996. Annals of the New York Academy of Sciences 828 (1997) 47-58
117. WHO Task Force on Post-Ovulatory Methods of Fertility Regulation. Medical abortion at 57 to 63 days' gestation with a lower dose of mifepristone and gameprost. A randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica 80 (2001) 447-451